ORYZON awarded with a grant for ORY-4001 from the ALS Association in the U.S. 04/12/2023 Healthcare Innovative drugs To explore Oryzon’s clinical candidate ORY-4001 in ALS. The ALS Association to provide 500,000 USD funding. Partners - Oryzon Genomics
Peaches Biotech receives the Innova Health 2023 Award for the most innovative project 15/11/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies It is a recognition of the company, its professionals and the advances achieved in its secretome-based therapies Partners - PEACHES BIOTECH S.L.
ORYZON announces Last Patient Last Visit in its Phase IIb PORTICO study for Borderline Per... 07/11/2023 Healthcare Access to innovation Innovative drugs Multiple primary endpoints include reduction in agitation and aggression and overall BPD disease improvement. Partners - Oryzon Genomics
VIVEbiotech has received the "Business Innovation" award at the XXXII edition of the Basqu... 24/10/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de... Partners - VIVEbiotech
#NewAseBioMember | "AseBio is the perfect opportunity to participate in the ecosystem of S... 25/10/2023 Healthcare Innovative drugs Meet NANODECAL, our new partner. We talked to its CEO, Roberto de la Rica. AseBio
New Step Forward in the Field of Thyroid Disruption Screening Method for Early Drug and Ch... 23/10/2023 Healthcare Drug discovery Innovative drugs Being this said, at Biobide they have published a new scientific research where it has been validated the Thyroid... Partners - Biobide
ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO... 10/10/2023 Healthcare Drug discovery Innovative drugs At the 36th European College of Neuropsychopharmacology congress (ECNP-2023). Partners - Oryzon Genomics
#BIOSPAIN2023 Interview | "The Administration of LAM561 Shows Promising Results in the Tr... 08/09/2023 Innovative drugs BioSpain We spoke with Cati Ana Rosselló, Head of CMC at Laminar Pharma, a Bronze Sponsor of BIOSPAIN 2023, about the results of... AseBio - Laminar Pharma
Gradient Denervation Technologies closes €14m Series A led by Sabadell Asabys 07/09/2023 Healthcare Innovative drugs The funds will enable the company to advance the clinical development of its unique, minimally invasive ultrasound-based... Partners - Asabys Partners
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park 24/08/2023 Healthcare Innovative drugs Advanced therapies The company specialises in the development of molecules for oncological and gastrointestinal immunological treatments... Partners - Parc Científic de Barcelona
